Nerelimomab (7.5 mg/kg, i.v. infusion) protected animals from death in a baboon model of recurrent bacteremia[1].
| Animal Model: | Baboon model of recurrent bacteremia (Challenged with E.coli)[1] |
| Dosage: | 7.5 mg/kg |
| Administration: | i.v. infusion |
| Result: | Improved organ function and attenuated cytokine and plasminogen activator inhibitor release. |
